When delivered by attenuated S. typhimurium, an MTDH/AEG-1-based DNA vaccine induces robust CD8+ cytotoxic-T-cell-mediated immune responses against breast cancer, displaying effectiveness in preventing tumor growth and metastasis [204]. Here, CD8A is linked to neoplasm.